跳至主要内容
临床试验/JPRN-jRCT1031210321
JPRN-jRCT1031210321招募中未知

The blood glucose fluctuation difference between weekly GH replacement and daily GH replacement - a single-center prospective study

Miyatsuka Takeshi0 个研究点目标入组 20 人开始时间: 2021年9月16日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 < 60age old(—)
性别
All

入选标准

  • The patients who undertake Daily GH replacement (norditropin, humatrope, genotropin, growject) from the Hospital director's permission date by March 31 st, 2023 are going to undergo sogroya.
  • The administration condition of GH preparation is limited to patients diagnosed with severe adult growth hormone deficiency. Diagnosis of adult growth hormone deficiency (AGHD) as per Japanese practice

排除标准

  • Before undertaking operations or presence of severe trauma.
  • Presence of malignant tumor(s).
  • Pregnant or likely to get pregnant.
  • Diabetes mellitus.
  • age: less than 20 years old or more than 60 years old

研究者

发起方
Miyatsuka Takeshi

相似试验